Back
Daiichi Sankyo Vs. Nxera Pharma Industry Stock Comparison
Sell
33
DSKYF
Daiichi Sankyo
Last Price:
30.50
Seasonality Move:
3.46%
Sell
30
SOLTF
Nxera Pharma
Last Price:
7.25
Seasonality Move:
5.96%
Sell
33
Daiichi Sankyo (DSKYF)
is a Sell
Is Daiichi Sankyo a Buy, Sell or Hold?
- The current Daiichi Sankyo [DSKYF] share price is $31.16. The Score for DSKYF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- DSKYF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $7.25. The Score for SOLTF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DSKYF Stock Price Chart
What is Daiichi Sankyo's stock price today?
-
The Daiichi Sankyo share price today is $31.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DSKYF is experiencing selling pressure, which indicates risk of future bearish movement.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $7.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing selling pressure, which indicates risk of future bearish movement.
DSKYF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.91 | Sell |
Relative Strength Index (14 RSI): | 45.96 | Sell |
Chaikin Money Flow: | -1923 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.19 - 34.09) | Sell |
Bollinger Bands (100): | (33.03 - 39.11) | Sell |
SOLTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 28.56 | Sell |
Chaikin Money Flow: | -3181 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.51 - 9.21) | Sell |
Bollinger Bands (100): | (8.43 - 10.25) | Sell |
DSKYF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.95 | Sell |
20-day SMA: | 32.55 | Sell |
50-day SMA: | 35.66 | Sell |
200-day SMA: | 34.15 | Sell |
8-day EMA: | 32.01 | Sell |
20-day EMA: | 32.73 | Sell |
50-day EMA: | 34.35 | Sell |
200-day EMA: | 34.08 | Sell |
SOLTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.39 | Sell |
20-day SMA: | 8.18 | Sell |
50-day SMA: | 8.7 | Sell |
200-day SMA: | 9.59 | Sell |
8-day EMA: | 7.45 | Sell |
20-day EMA: | 7.96 | Sell |
50-day EMA: | 8.59 | Sell |
200-day EMA: | 9.66 | Sell |
Daiichi Sankyo Earnings Growth & DSKYF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Daiichi Sankyo Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nxera Pharma Technical Analysis
Oct 17 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |